🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1265
-0.0125 (-8.99%)
At close: Nov 20, 2026

Northwest Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.733.042.182.136.9715.17
Cash & Short-Term Investments
0.733.042.182.136.9715.17
Cash Growth
-84.10%39.77%2.31%-69.48%-54.08%51.95%
Receivables
-0.31----
Prepaid Expenses
1.72.171.8922.462.12
Total Current Assets
2.435.524.064.139.4317.29
Property, Plant & Equipment
20.9221.620.3821.4619.6419.92
Goodwill
0.630.630.630.630.630.63
Other Intangible Assets
51.7853.191.291.291.291.29
Other Long-Term Assets
0.380.360.370.360.351.04
Total Assets
76.1481.2926.7327.8731.3240.16

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
31.0130.8216.9710.2410.696.98
Accrued Expenses
--4.45---
Short-Term Debt
11.659.4714.193.9415.47.1
Current Portion of Long-Term Debt
40.8832.720.1916.540.140.14
Current Portion of Leases
0.480.370.330.310.350.32
Other Current Liabilities
6.9218.3512.1514.1799.43119.24
Total Current Liabilities
90.9491.768.2745.2126.01133.77
Long-Term Debt
11.9817.8828.320.315.9925.16
Long-Term Leases
4.844.414.444.454.375.23
Long-Term Deferred Tax Liabilities
12.9813.17----
Other Long-Term Liabilities
1.71.74.74.95--
Total Liabilities
122.44128.86105.7174.92136.37164.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1.771.571.331.181.070.95
Additional Paid-In Capital
1,4861,4431,3451,2911,1651,067
Retained Earnings
-1,545-1,504-1,443-1,360-1,297-1,192
Treasury Stock
-0.01-0.01----
Comprehensive Income & Other
-0.19-12.961.463.070.28
Total Common Equity
-56.7-60.28-94.49-65.77-128.1-123.99
Shareholders' Equity
-46.3-47.57-78.98-47.06-105.04-123.99
Total Liabilities & Equity
76.1481.2926.7327.8731.3240.16

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
69.8464.8367.4445.5626.2537.94
Net Cash (Debt)
-69.11-61.79-65.27-43.43-19.29-22.77
Net Cash Growth
------
Net Cash Per Share
-0.04-0.04-0.05-0.04-0.02-0.02
Filing Date Shares Outstanding
1,8121,6071,3911,1901,073960.02
Total Common Shares Outstanding
1,7621,5671,3291,1761,068948.45
Working Capital
-88.51-86.18-64.21-41.08-116.58-116.48
Book Value Per Share
-0.03-0.04-0.07-0.06-0.12-0.13
Tangible Book Value
-109.11-114.09-96.41-67.69-130.02-125.91
Tangible Book Value Per Share
-0.06-0.07-0.07-0.06-0.12-0.13
Land
-0.090.090.090.080.09
Machinery
-5.923.693.262.542.11
Construction In Progress
----2.03-
Leasehold Improvements
-19.0817.9717.7913.0713.91